Streetbeat News

AHI

Advanced Human Imaging Limited

https://www.advancedhumanimaging.com

Industry

Software - Application

Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.

Open

N/A

Mkt cap

13M

Volume

N/A

High

1.50

P/E Ratio

-4.69

52-wk high

2.56

Low

1.50

Div yield

N/A

52-wk low

1.41

Several healthcare stocks experienced significant movement in Friday's pre-market session. Advanced Health (AHI), Tivic Health Systems (TIVC), Sensus Healthcare (SRTS), Twist Bioscience (TWST), XTL Biopharmaceuticals (XTLB), and Natera (NTRA) saw gains, while Mesoblast (MESO), Assertio Holdings (ASRT), INVO Bioscience (INVO), Tandem Diabetes Care (TNDM), TransMedics Gr (TMDX), and T2 Biosystems (TTOO) experienced losses.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 3:24 pm

Tupperware Brands (TUP) announced a debt restructuring agreement, reducing and reallocating about $150M of cash interest and fees, and extending the maturity of about $348M of principal to FY27. Advanced Health Intelligence (AHI) announced an exclusive license deal with Changlin Network Technology Ltd. Amazon.com (AMZN) reported Q2 sales of $134.40B, beating the $131.54B estimate, and an adjusted EPS of $0.63, beating the $0.34 estimate.

Portfolio Pulse from ryanfaloona@benzinga.com

August 04, 2023 | 3:17 pm

Advanced Health Intelligence (AHI) shares resumed trading higher premarket following the announcement of a license deal in China. The deal is expected to boost AHI's market presence in China.

Portfolio Pulse from Charles Gross

August 04, 2023 | 3:06 pm

Trading of Advanced Health Intelligence (AHI) shares is set to resume at 7:10 AM ET.

Portfolio Pulse from Charles Gross

August 04, 2023 | 3:05 pm

Advanced Health Intelligence Ltd (ASX: AHI) (NASDAQ:AHI) has signed an exclusive, perpetual license agreement with Shanghai-based Changlin Network Technology Ltd. The deal includes an upfront payment of $10 million to AHI, an annual license fee of $5 million, and a 25% revenue share of gross sales. Changlin, which plans to go public in 2024, will initially issue a 50% holding to AHI, expected to be restructured to 25% but not less than 20% at the IPO. The deal is contingent on Changlin securing financing and SAFE approval in China.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:55 pm

Advanced Health Intelligence Ltd (AHI) has signed an exclusive, perpetual license agreement with Shanghai-based Changlin Network Technology Ltd. The deal includes an upfront payment of $10 million to AHI, an annual license fee of $5 million, and a 25% revenue share of gross sales. Changlin, planning an IPO in 2024, will initially issue a 50% holding to AHI, which will later be reduced to 25-20%. The deal is contingent on Changlin securing financing and SAFE approval in China.

Portfolio Pulse from Charles Gross

August 04, 2023 | 2:54 pm

Trading of Advanced Health Intelligence (AHI) shares has been halted due to pending news.

Portfolio Pulse from Charles Gross

August 04, 2023 | 12:43 pm

Advanced Health Intelligence (AHI) has executed a binding exclusive, perpetual license with Shanghai-based Changlin Network Technology. This news has led to a rise in AHI's share prices.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:58 am

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Trxade Health (MEDS), Advanced Health (AHI), Applied Therapeutics (APLT), TC BioPharm (TCBP), TRACON Pharma (TCON), and Frequency Therapeutics (FREQ) saw their shares rise, with Trxade Health leading the gainers with a 63.3% increase. On the other hand, Adamis Pharmaceuticals (ADMP), Aptevo Therapeutics (APVO), Biophytis (BPTS), Nevro (NVRO), SmileDirectClub (SDC), and Bio-Path Hldgs (BPTH) experienced declines, with Adamis Pharmaceuticals leading the losers with a 63.4% decrease.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:51 am

Trading of Advanced Health Intelligence (AHI) shares has resumed.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 11:25 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.